Mental Health

Welligent and Greenspace Health Announce Strategic Integration

TAMPA, Fla.--(BUSINESS WIRE)--#ContinuumCloud--Welligent, a part of the ContinuumCloud spectrum of solutions for social good, and Greenspace Health are pleased to…

2 years ago

Los Angeles Tourism Celebrates Global Meetings Industry Day by Spotlighting How Meetings and Conventions Benefit All Angelenos

LOS ANGELES--(BUSINESS WIRE)--Today, Los Angeles Tourism & Convention Board (Los Angeles Tourism) is proud to join our colleagues across the…

2 years ago

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

Lack of early symptom improvement is not predictive of final responder statusMALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics,…

2 years ago

Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders

Company not implementing a reverse split at this timeTop line results forthcoming for company's phase 3 OnTarget trial of crofelemer…

2 years ago

24-Provider Health Center Leverages eClinicalWorks and the healow No-Show Prediction AI Model to Enhance Access to Care

Federally Qualified Health Center (FQHC) HealthCare Choices NY, Inc. successfully increases show rate by 155% for appointments with a high…

2 years ago

Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing

The new Gen-3 HALO™ Clarity 15 milliamp (mA) The new Gen-3 HALO™ Clarity 15 milliamp (mA) The new Gen-3 HALO™…

2 years ago

Clearmind Medicine CEO Issues Letter to Shareholders

Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (“Clearmind” or the “company”), a clinical-stage…

2 years ago

Celly Announces Increase of Term Loan

Toronto, Ontario--(Newsfile Corp. - April 8, 2024) - Celly Nutrition Corp. ("Celly Nu" or the "Company"), announced today that it…

2 years ago

Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq’s Bid Price Requirement

Top line results forthcoming for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrheaSAN FRANCISCO,…

2 years ago

Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that…

2 years ago